Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by PoorOpinionon Sep 28, 2018 2:36pm

164 Views

Post# 28711143

RE:RE:RE:RE:RE:RealityCheck4U here - after 3+ years as TH holder

SPCEO1 wrote: It is the end of the month and quarter and the shorts are trying to boost their performance by knocking the stock lower at the close. I was hoping our shorts were more passive ones related to hedging the convertible but this new post indicates they are more the natsy type. Hopefully, the company is able to produce results to blow them out of the water sooner rather than later so such silliness can stop.

I think you're giving somebody with crass and moronic comments too much credit. Who would pay for that trash?

Bullboard Posts

How one company is disrupting PoC testing